
Biotech firm gets US$33M boost for Ottawa-developed COVID-19 vaccine targeting new variants
Massachusetts-based VBI Vaccines began clinical trials at the Ottawa Hospital this week on the first version of its product.
Biotech firm gets US$33M boost for Ottawa-developed COVID-19 vaccine targeting new variants
Massachusetts-based VBI Vaccines began clinical trials at the Ottawa Hospital this week on the first version of its product.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
Canadian Trademark Office to send notices to random trademark owners to prove use of their marks
Don’t Let Your Passion Kill Your Business
AI and data Governance: 3 steps to kick-start your journey
EVENT ALERT: Mayor's Breakfast with Ontario Finance Minister on Wednesday, Dec. 4 @ City Hall